HansBiomed Corporation (KOSDAQ:042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
21,100
-100 (-0.47%)
At close: Sep 9, 2026

HansBiomed Revenue

HansBiomed had revenue of 36.35B KRW in the quarter ending June 30, 2026, with 64.95% growth. This brings the company's revenue in the last twelve months to 124.81B, up 45.85% year-over-year. In the fiscal year ending September 30, 2025, HansBiomed had annual revenue of 89.78B with 10.65% growth.

Revenue (ttm)
124.81B
Revenue Growth
+45.85%
P/S Ratio
2.41
Revenue / Employee
396.23M
Employees
315
Market Cap
300.91B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202589.78B8.64B10.65%
Sep 30, 202481.14B3.11B3.98%
Sep 30, 202378.03B3.57B4.80%
Sep 30, 202274.46B15.36B25.99%
Sep 30, 202159.10B-21.00B-26.22%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
ROKIT Healthcare32.81B
Genome & Company24.46B
S.Biomedics16.49B
curacle co.,ltd.8.24B
IntoCell3.19B
Kangstem Biotech3.03B
Inventage Lab2.47B
AprilBio725.35M
Revenue Rankings